Certain high priority groups more likely to stop taking HIV prevention treatment, study finds

​A large, detailed look at patients taking HIV-prevention drug therapy finds strong adherence soon after patients get the prescription, but less consistent use thereafter, particularly among groups considered high priority for receiving the medication.